Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event

v3.2.0.727
Subsequent Event
6 Months Ended
Jun. 30, 2015
Disclosure Subsequent Events Additional Information [Abstract]  
Subsequent Event

NOTE 13—SUBSEQUENT EVENT

Stock-Based Compensation

Effective July 13, 2015, the Compensation Committee of the Board awarded 870,000 stock-settled restricted stock units and granted non-qualified stock options to purchase up to 870,000 shares of Biolase common stock to its President and Chief Executive Officer in connection with his employment agreement with Biolase.